Your browser doesn't support javascript.
loading
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics.
Murugaiyan, Jayaseelan; Kumar, P Anand; Rao, G Srinivasa; Iskandar, Katia; Hawser, Stephen; Hays, John P; Mohsen, Yara; Adukkadukkam, Saranya; Awuah, Wireko Andrew; Jose, Ruiz Alvarez Maria; Sylvia, Nanono; Nansubuga, Esther Patience; Tilocca, Bruno; Roncada, Paola; Roson-Calero, Natalia; Moreno-Morales, Javier; Amin, Rohul; Kumar, Ballamoole Krishna; Kumar, Abishek; Toufik, Abdul-Rahman; Zaw, Thaint Nadi; Akinwotu, Oluwatosin O; Satyaseela, Maneesh Paul; van Dongen, Maarten B M.
Afiliación
  • Murugaiyan J; Department of Biological Sciences, SRM University-AP, Guntur District, Amaravati 522240, India.
  • Kumar PA; Department of Veterinary Microbiology, NTR College of Veterinary Science, Sri Venkateswara Veterinary University, Gannavaram 521102, India.
  • Rao GS; Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, Sri Venkateswara Veterinary University, Tirupati 517502, India.
  • Iskandar K; Department of Mathématiques Informatique et Télécommunications, Université Toulouse III, Paul Sabatier, INSERM, UMR 1295, 31000 Toulouse, France.
  • Hawser S; INSPECT-LB: Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban, Beirut 6573, Lebanon.
  • Hays JP; Faculty of Pharmacy, Lebanese University, Beirut 6573, Lebanon.
  • Mohsen Y; IHMA Europe Sàrl, 1870 Monthey, Switzerland.
  • Adukkadukkam S; Department of Medical Microbiology, Infectious Diseases, Erasmus University Medical Centre (Erasmus MC), 3015 GD Rotterdam, The Netherlands.
  • Awuah WA; Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria 21544, Egypt.
  • Jose RAM; Infectious Disease Clinical Pharmacist, Antimicrobial Stewardship Department, International Medical Center Hospital, Cairo 11511, Egypt.
  • Sylvia N; Department of Biological Sciences, SRM University-AP, Guntur District, Amaravati 522240, India.
  • Nansubuga EP; Faculty of Medicine, Sumy State University, 40007 Sumy, Ukraine.
  • Tilocca B; Research Coordination and Support Service, National Institute of Health (ISS) Viale Regina -Elena, 299, 00161 Rome, Italy.
  • Roncada P; Infectious Diseases Institute (IDI), College of Health Sciences, Makerere University, Kampala 7072, Uganda.
  • Roson-Calero N; School of Medicine, University of Leeds, Leeds LS2 9JT, UK.
  • Moreno-Morales J; Department of Health Science, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
  • Amin R; Department of Health Science, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
  • Kumar BK; ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
  • Kumar A; ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
  • Toufik AR; James P Grant School of Public Health, BRAC University, Dhaka 1212, Bangladesh.
  • Zaw TN; Nitte (Deemed to be University), Division of Infectious Diseases, Nitte University Centre for Science Education and Research, Deralakatte, Mangalore 575018, India.
  • Akinwotu OO; Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.
  • Satyaseela MP; Faculty of Medicine, Sumy State University, 40007 Sumy, Ukraine.
  • van Dongen MBM; Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Antibiotics (Basel) ; 11(2)2022 Feb 04.
Article en En | MEDLINE | ID: mdl-35203804
ABSTRACT
Antibiotic resistance, and, in a broader perspective, antimicrobial resistance (AMR), continues to evolve and spread beyond all boundaries. As a result, infectious diseases have become more challenging or even impossible to treat, leading to an increase in morbidity and mortality. Despite the failure of conventional, traditional antimicrobial therapy, in the past two decades, no novel class of antibiotics has been introduced. Consequently, several novel alternative strategies to combat these (multi-) drug-resistant infectious microorganisms have been identified. The purpose of this review is to gather and consider the strategies that are being applied or proposed as potential alternatives to traditional antibiotics. These strategies include combination therapy, techniques that target the enzymes or proteins responsible for antimicrobial resistance, resistant bacteria, drug delivery systems, physicochemical methods, and unconventional techniques, including the CRISPR-Cas system. These alternative strategies may have the potential to change the treatment of multi-drug-resistant pathogens in human clinical settings.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Antibiotics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Antibiotics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: India